Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
about
P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions.Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancerNew therapies for advanced, recurrent, and metastatic endometrial cancers.HOXB9 promotes endometrial cancer progression by targeting E2F3.
P2860
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic importance of CDK4/ ...... without adjuvant chemotherapy.
@en
type
label
Prognostic importance of CDK4/ ...... without adjuvant chemotherapy.
@en
prefLabel
Prognostic importance of CDK4/ ...... without adjuvant chemotherapy.
@en
P2093
P2860
P356
P1476
Prognostic importance of CDK4/ ...... without adjuvant chemotherapy.
@en
P2093
Aki Miyasaka
Daichi Maeda
Daisuke Aoki
Hideki Ishihara
Kanako Inaba
Katsutoshi Oda
Kei Kawana
Kenbun Sone
Masahi Fukayama
Masako Ikemura
P2860
P2888
P304
P356
10.1038/BJC.2015.369
P407
P577
2015-11-10T00:00:00Z